Clinical Trial Update: Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

View source ↗

Summary

Real-world study evaluating a biosimilar trastuzumab for breast cancer; the trial status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab biosimilar

Snippet

Sponsor: Libbs Farmacêutica LTDA | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING